INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 444m ago
House PTR44m ago
SEC 13F44m ago
Robinhood Chain43m ago

Results

82,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$33K
200 sh
Dec 30, 2025
Page 1794 of 2053
← PrevNext →
Dec 31, 2025
traded Dec 30, 2025
+1d
SEC Form 4

Evidence

3
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
45.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

3
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
124 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

2
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Option exercise · 10b5-1 plan
M$60K
8,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

2
MA
Mahdessian AraDirector, Chief Executive Officer
TTANServiceTitan, Inc.
Derivative conversion
C—
19.0K sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

2
MA
Mahdessian AraDirector, Chief Executive Officer
TTANServiceTitan, Inc.
Derivative conversion
C—
19.0K sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Derivative conversion · 10b5-1 plan
C—
32.4K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1,292
124 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$25K
2,395 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$27K
2,605 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
2,500 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,395 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
100 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,605 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Option exercise · 10b5-1 plan
M—
8,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1,042
100 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

56
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$10.71M
572.4K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

55
FH
Frank Edward H.Director
RKLBRocket Lab Corp
Open-market sale
SELL$193K
2,500 sh
Dec 23, 2025Dec 30, 2025
traded Dec 23, 2025
+7dSEC Form 4

Evidence

49
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$4.99M
266.6K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

49
TA
Tpg Gp A, Llc10% Owner
NANATPG Twin Brook Capital Income Fund
Open-market purchase
BUY$100.00M
3.98M sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

49
SL
Scavo Robert L.Chief Information Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$1.23M
65.7K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$300K
15.5K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
BD
Brazeal Mark DavidChief Legal & Corp Affairs Ofc
AVGOBroadcom Inc.
Open-market sale
SELL$9.13M
25.9K sh
Dec 26, 2025Dec 30, 2025
traded Dec 26, 2025
+4dSEC Form 4

Evidence

42
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$644K
33.2K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
JJ
Joyce Christopher JChief Legal and Admin. Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$286K
15.3K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

41
JW
Jones Jack W.Director, President & CEO
FKYSFIRST KEYSTONE CORP
Open-market purchase
BUY$26K
1,400 sh
Dec 30, 2025Dec 30, 2025
traded Dec 30, 2025
+0dSEC Form 4

Evidence